Publications by authors named "Tabea Klaus"

Claim this Profile
C
Catalytic Inhibition of KAT6/KAT7 Enhances the Efficacy and Overcomes Primary and Acquired Resistance to Menin Inhibitors in MLL Leukemia.
Shellaina J V Gordon, Florian Perner, Laura MacPherson, Katie A Fennell, Daniela V Wenge, Tabea Klaus

Cancer Discov· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The histone-methyltransferase DOT1L cooperates with LSD1 to control cell division in blast-phase MPN.
Karl Kapahnke, Thomas Plenge, Tabea Klaus, Manoj K Gupta, Disha Anand

Leukemia· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML.
Viktor Fetsch, Lennard Frederik Schwöbel, Ezgi Ozyerli-Goknar, Anna-Verena Stell, Marco Punta, Tabea Klaus

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemia.
Shellaina J V Gordon, Florian Perner, Laura MacPherson, Daniela V Wenge, Wallace Bourgeois, Tabea Klaus

bioRxiv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis